These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 7043937

  • 21. The action of benzbromarone in relation to age, sex and accompanying diseases.
    Ferber H, Bader U, Matzkies F.
    Adv Exp Med Biol; 1980; 122A():287-94. PubMed ID: 6999850
    [Abstract] [Full Text] [Related]

  • 22. [Hypouricemizing effect of benzbromarone. Study of 24 cases (preliminary results)].
    Sternon J, Kocheleff P, Couturier E, Balasse E, Vanden Abeele P.
    Acta Clin Belg; 1967; 22(5):285-93. PubMed ID: 5621966
    [No Abstract] [Full Text] [Related]

  • 23. [Excretion and serum concentrations of allopurinol, oxipurinol and oxipurines in combined treatment with allopurinol and benzbromarone in increasing doses].
    Mertz DP, Borner K.
    Med Welt; 1983 Sep 09; 34(36):974-9. PubMed ID: 6633222
    [No Abstract] [Full Text] [Related]

  • 24. [Normurat (benzbromaron) in the treatment of gout].
    Bosmanský K, Trnavský K.
    Z Rheumatol; 1979 Sep 09; 38(9-10):342-8. PubMed ID: 525067
    [Abstract] [Full Text] [Related]

  • 25. Ten years' experience with benzbromarone in the management of gout and hyperuricaemia.
    Masbernard A, Giudicelli CP.
    S Afr Med J; 1981 May 09; 59(20):701-6. PubMed ID: 7221794
    [Abstract] [Full Text] [Related]

  • 26. [Therapy of hyperuricemia and gout. Effect of a combination therapy of allopurinol with benzbromarone].
    Matzkies F.
    Fortschr Med; 1983 May 26; 101(20):953-9. PubMed ID: 6873850
    [No Abstract] [Full Text] [Related]

  • 27. Treatment of gout with alternate-day hypo-uricaemic drugs.
    Nishizawa T, Nishida Y, Masuda T, Akaoka I.
    Rheumatol Rehabil; 1978 Aug 26; 17(3):143-9. PubMed ID: 705170
    [No Abstract] [Full Text] [Related]

  • 28. [Efficacy and tolerance of a new benzbromarone preparation].
    Jelke K, Neubauer M, Krause G, Jüttner A, Angar T, Grosse-Kielisch C, Bach GL.
    Med Welt; 1980 May 23; 31(21):821-2. PubMed ID: 7392938
    [No Abstract] [Full Text] [Related]

  • 29. [Benziodarone in hyperuricemia due to renal insufficiency].
    Boine L.
    Minerva Med; 1973 Jan 20; 64(4):157-9. PubMed ID: 4568713
    [No Abstract] [Full Text] [Related]

  • 30. [The use of Allomaron in treating hyperuricemia].
    Balkarov IM.
    Ter Arkh; 1994 Jan 20; 66(1):40-2. PubMed ID: 8146793
    [No Abstract] [Full Text] [Related]

  • 31. Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol.
    Reinders MK, van Roon EN, Jansen TL, Delsing J, Griep EN, Hoekstra M, van de Laar MA, Brouwers JR.
    Ann Rheum Dis; 2009 Jan 20; 68(1):51-6. PubMed ID: 18250112
    [Abstract] [Full Text] [Related]

  • 32. [Clinical studies on hyperuricemia and gout after transplantation].
    Imanishi M, Ikegami M, Ishii T, Nishioka T, Uemura T, Kunikata S, Kanda H, Matsuura T, Akiyama T, Kurita T.
    Hinyokika Kiyo; 1990 Aug 20; 36(8):893-6. PubMed ID: 2239590
    [Abstract] [Full Text] [Related]

  • 33. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.
    Perez-Ruiz F, Calabozo M, Pijoan JI, Herrero-Beites AM, Ruibal A.
    Arthritis Rheum; 2002 Aug 20; 47(4):356-60. PubMed ID: 12209479
    [Abstract] [Full Text] [Related]

  • 34. [Uric acid-induced diseases. 2. Therapy].
    Matzkies F.
    Fortschr Med; 1980 Apr 10; 98(14):512-8. PubMed ID: 7372248
    [No Abstract] [Full Text] [Related]

  • 35. Clinical evaluation of benzbromarone: a new uricosuric drug.
    Sorensen LB, Levinson DJ.
    Arthritis Rheum; 1976 Apr 10; 19(2):183-90. PubMed ID: 1259799
    [Abstract] [Full Text] [Related]

  • 36. [Diet and pharmacologic therapy of hyperuricemias in the aged].
    Ravera M, Ugo C.
    G Gerontol; 1971 Mar 10; 19(3):193-9. PubMed ID: 5143398
    [No Abstract] [Full Text] [Related]

  • 37. [Effect of benzbromarone on serum uric acid level and uric acid excretion of patients with gout].
    Zöllner N, Griebsch A, Fink JK.
    Dtsch Med Wochenschr; 1970 Nov 27; 95(48):2405-12. PubMed ID: 5480261
    [No Abstract] [Full Text] [Related]

  • 38. [Pathogenesis and treatment of fast-induced hyperuricemia using benzbromarone].
    Schräpler P, Schulz E.
    Med Welt; 1976 Mar 19; 27(12):575-81. PubMed ID: 1263801
    [No Abstract] [Full Text] [Related]

  • 39. [Long lasting normalization of uric acid after combination therapy with 300 mg allopurinol and 60 mg benzbromarone in patients with gout and hyperuricemia].
    Matzkies F.
    Med Klin (Munich); 1992 Sep 15; 87(9):460-2. PubMed ID: 1406482
    [Abstract] [Full Text] [Related]

  • 40. [Isolated or combined drug therapy of hyperuricemia?].
    Mertz DP.
    Dtsch Med Wochenschr; 1977 Jul 29; 102(30):1096-7. PubMed ID: 891391
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.